Cite
Aldoss I, Zhang J, Mei M, et al. Venetoclax and hypomethylating agents in FLT3-mutated acute myeloid leukemia. Am J Hematol. 2020;doi: 10.1002/ajh.25929.
Aldoss, I., Zhang, J., Mei, M., Al Malki, M. M., Arslan, S., Ngo, D., Aribi, A., Ali, H., Sandhu, K., Salhotra, A., Koller, P., Khaled, S., Artz, A., Snyder, D., Nakamura, R., Forman, S. J., Stein, A. S., Marcucci, G., & Pullarkat, V. (2020). Venetoclax and hypomethylating agents in FLT3-mutated acute myeloid leukemia. American journal of hematology, . https://doi.org/10.1002/ajh.25929
Aldoss, Ibrahim, et al. "Venetoclax and hypomethylating agents in FLT3-mutated acute myeloid leukemia." American journal of hematology vol. (2020). doi: https://doi.org/10.1002/ajh.25929
Aldoss I, Zhang J, Mei M, Al Malki MM, Arslan S, Ngo D, Aribi A, Ali H, Sandhu K, Salhotra A, Koller P, Khaled S, Artz A, Snyder D, Nakamura R, Forman SJ, Stein AS, Marcucci G, Pullarkat V. Venetoclax and hypomethylating agents in FLT3-mutated acute myeloid leukemia. Am J Hematol. 2020 Jul 06; doi: 10.1002/ajh.25929. Epub 2020 Jul 06. PMID: 32628327.
Copy
Download .nbib